PATENT CLAIM ANALYSIS

Application Number: 16110440
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "023000"]

Abstract:
Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.

Claim (Index 11):
The method of  claim 1 , wherein the aqueous solution further comprises about 0.1 wt % hypromellose, about 5 wt % sorbitol, and from about 0.1 wt % to about 2 wt % benzyl alcohol.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 96.0
- Lexical Diversity: 1.51163
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14576357', '14882857', '14950707', '15335145', '14659472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8068946153057893
- 35 USC 102 Novelty (BERT): 0.5518569975809118
- Combined Prediction Score: 0.7813908535333016
- Mean Citation Score: 371.244514
- Max Citation Score: 434.96957
- Similarity Product: 297.8763519407176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test